Analyst Ratings For Pacira BioSciences
Analyst Ratings For Pacira BioSciences
帕西拉生物科學的分析師評級
6 analysts have shared their evaluations of Pacira BioSciences (NASDAQ:PCRX) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三個月來，有6位分析師分享了他們對Pacira BioSciences（納斯達克股票代碼：PCRX）的評估，表達了看漲和看跌的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $46.67, a high estimate of $57.00, and a low estimate of $43.00. This current average has decreased by 4.76% from the previous average price target of $49.00.
分析師12個月目標股價的見解已經公佈，平均目標股價爲46.67美元，最高估計爲57.00美元，低估值爲43.00美元。目前的平均價格較之前的平均目標價49.00美元下降了4.76％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
The perception of Pacira BioSciences by financial experts is analyzed through recent analyst actions...
通過分析師最近的行動，分析了...
登入免費觀看全文
登入/註冊